About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in San Diego | 206 Studies

Clinical Trials Breast CancerSan Diego

Breast Cancer Clinical Trials in San Diego

Find 206 clinical trials for breast cancer near San Diego, California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in San Diego

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 206 trials

RecruitingEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in…NCT05879926·Birmingham, Alabama and 1260 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult PatientsThe goal of this clinical trial is to compare patient-centered outcomes when screening digital breast tomosynthesis (DBT) exams are interpreted with versus without a leading…NCT06934239·Los Angeles, California and 5 others

RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors.NCT05579366·Phoenix, Arizona and 65 others

CompletedSurgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast CancerRATIONALE: Removing the sentinel lymph nodes and examining them under a microscope may help plan more effective surgery for breast cancer.NCT00003830·Mobile, Alabama and 77 others

CompletedAssessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryThis phase II trial studies how well biopsy of breast after chemotherapy works in predicting pathologic response in patients with stage II-IIIA breast cancer undergoing breast…NCT03188393·Birmingham, Alabama and 380 others

RecruitingShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabThis phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive…NCT06876714·Phoenix, Arizona and 689 others

UnknownTPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and SurgeryThis phase II trial studies how well TPIV100 and sargramostim work in treating patients with HER2 positive, stage II-III breast cancer that has residual disease after chemotherapy…NCT04197687·Scottsdale, Arizona and 29 others

CompletedSentiMag® Intraoperative Comparison in Breast CancerThe purpose of this pivotal study is to provide prospective evidence that the SentiMag®/SiennaXP® is safe and non-inferior to the current standard of care for lymph node…NCT02336737·La Jolla, California and 5 others

SuspendedTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialThis phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive…NCT06671912·Anchorage, Alaska and 731 others

CompletedSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast tumor cells.NCT00066690·Birmingham, Alabama and 499 others

CompletedA Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending-dose escalation study and expansion study designed to define a maximum tolerated dose and/or recommended dose of XmAb22841 monotherapy…NCT03849469·Encinitas, California and 27 others

Active not recruitingPragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium TrialA pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and followed longitudinally for cardiovascular…NCT02603341·Birmingham, Alabama and 39 others

CompletedReproductive Health Survivorship Care Plan PilotMost young breast cancer patients undergo chemotherapy and/or endocrine therapy, treatments that impair ovarian function and result in significant reproductive health late effects.NCT02176083·La Jolla, California and 1 other

Not yet recruitingCollaborative Research: Multiscale Modeling and Intervention for Improving Long-Term MedicationThe goal of this study is to learn about the impact of an integrated medication monitoring system in breast cancer survivors aged 21-70 who are prescribed endocrine therapy.NCT06865755·San Diego, California

RecruitingThe PREDICT Registry:This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions.NCT03448926·Scottsdale, Arizona and 29 others

CompletedPhase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast CancerFB-7 is a Phase II, multi-center randomized study of neratinib in combination with weekly paclitaxel with or without trastuzumab followed by doxorubicin and cyclophosphamide (AC)…NCT01008150·Loma Linda, California and 41 others

RecruitingA Study of Sofe-M in Participants With Selected Advanced Solid TumorsThe purpose of this study is to find out whether the study drug, Sofetabart Mipitecan (LY4170156), is safe, tolerable and effective in participants with advanced solid tumors.NCT06400472·Scottsdale, Arizona and 23 others

Active not recruitingMobile Health for Adherence in Breast Cancer PatientsThis clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text…NCT06112613·Fairbanks, Alaska and 505 others

RecruitingA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsThe purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in participants with advanced, or metastatic solid tumors including…NCT06465069·Duarte, California and 38 others

CompletedSentinel Lymph Node Mapping Post-Injection Site PainThis is a pain survey study that will compare the level of discomfort experienced by breast cancer patients after injection of either technetium-labeled sulfur colloid or…NCT02065232·San Diego, California

Page 1 of 11Next

Other Conditions in San Diego

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma